Human GLP-1 medications like Ozempic (semaglutide) and Wegovy are not approved for cats and can cause dangerous complications including severe hypoglycemia, GI distress, and electrolyte imbalances
They all operate within the growth hormone (GH) axis and are staples in research for that very reason
They do not tell us that subcutaneous GHK-Cu makes human facial skin firmer, smoother, or younger-looking, and they do not establish a human dose, schedule, or safety margin
Now, to bring all of this back to GLP-1, in this Ranana study in the journal gut in 1996, they took people and separated them into two groups
Chicago Buse, John B, Helene Nordahl Christensen, Brian J Harty, Mark J Cziraky, Vincent J Willey, and Simon Skibsted